Cumberland Pharmaceuticals Inc. (CPIX) vs Insight Molecular Diagnostics Inc. (IMDX)
A side-by-side comparison of Cumberland Pharmaceuticals Inc. and Insight Molecular Diagnostics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CPIX
Cumberland Pharmaceuticals Inc.
$7.17HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
IMDX
Insight Molecular Diagnostics Inc.
$3.38HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
Total return — CPIX vs IMDX
growth of $100 · dividends reinvested · last 10yCPIX +70.7% (+5.5%/yr)IMDX -96.9% (-29.4%/yr)CPIX compounded faster over this window
Log scale — wide-divergence pair
CPIX IMDX
CPIX vs IMDX: by the numbers
- •IMDX is the larger company ($109M vs $107M market cap).
- •Both run net losses; CPIX's is the smaller (-33.92% vs -2955.63% net margin).
- •IMDX grew revenue faster over the past five years (27.24% vs 3.53% CAGR).
- •CPIX pays a dividend (21.16% yield), while IMDX has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CPIX | IMDX |
|---|---|---|
| P/S ratio | 3.44 | 65.35 |
| P/B ratio | 6.16 | N/A |
Profitability
| Metric | CPIX | IMDX |
|---|---|---|
| Gross margin | 83.37% | 11.17% |
| Operating margin | -6.27% | -754.08% |
| Net margin | -33.92% | -2955.63% |
| ROE | -60.82% | N/A |
| ROIC | -34.77% | -223.06% |
Dividends
| Metric | CPIX | IMDX |
|---|---|---|
| Dividend yield | 21.16% | N/A |
Growth (annualized)
| Metric | CPIX | IMDX |
|---|---|---|
| Revenue CAGR (5Y) | 3.53% | 27.24% |
| Total return CAGR (5Y) | 25.62% | -44.39% |
Frequently asked
- Which has grown faster, CPIX or IMDX?
- Over the past five years, IMDX grew revenue faster — CPIX at a 3.53% CAGR versus IMDX at 27.24%.
- Does CPIX or IMDX pay a bigger dividend?
- CPIX pays a dividend (21.16% yield), while IMDX has no payments in the available dividend history.
- How have CPIX and IMDX total returns compared?
- Over the past 10 years, CPIX delivered 5.52% and IMDX delivered -29.11% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cumberland Pharmaceuticals dividend yieldCumberland Pharmaceuticals ROEInsight Molecular Diagnostics ROECumberland Pharmaceuticals operating marginInsight Molecular Diagnostics operating marginCumberland Pharmaceuticals revenue growthInsight Molecular Diagnostics revenue growthCumberland Pharmaceuticals free cash flowInsight Molecular Diagnostics free cash flow
Cumberland Pharmaceuticals & Insight Molecular Diagnostics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.